Dualyx

Ghent, Belgium

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

$43.5M raised

May 2023

Series A

Top Investors

HTGF (High-Tech Gruenderfonds)Andera Partners Fountain Healthcare Partners Forbion Capital Partners BioGeneration Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dualyx

How much funding has Dualyx raised?

Dualyx has raised $43.5M in total funding. The most recent round was Series A. The last funding was announced in May 2023.

Who are Dualyx's investors?

Dualyx's investors include HTGF (High-Tech Gruenderfonds), Andera Partners, Fountain Healthcare Partners, Forbion Capital Partners, BioGeneration Ventures.

Where is Dualyx headquartered?

Dualyx is headquartered in Ghent, Belgium.

What does Dualyx do?

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

What stage is Dualyx at?

Dualyx is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 15, 2023.

MLA

"Dualyx — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/dualyx. Accessed July 2, 2026.

APA

VCBacked. (2023). Dualyx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/dualyx

Wikipedia (cite web)

{{cite web |title=Dualyx — Funding & Investors |url=https://www.vcbacked.co/company/dualyx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 15, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K